In silico resources to assist in the development and evaluation of physiologically-based kinetic models

被引:37
|
作者
Madden J.C. [1 ]
Pawar G. [1 ,2 ]
Cronin M.T.D. [1 ]
Webb S. [3 ]
Tan Y.-M. [4 ]
Paini A. [5 ]
机构
[1] School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool
[2] Pharmacy and Therapeutics Section, School of Clinical and Experimental Medicine, Medical School Building, University of Birmingham, Edgbaston
[3] Department of Applied Mathematics, Liverpool John Moores University, Byrom Street, Liverpool
[4] U.S. Environmental Protection Agency, Office of Pesticide Programs, Health Effects Division, 109 TW Alexander Dr, Research Triangle Park, 27709, NC
[5] European Commission Joint Research Centre (JRC), Ispra, VA
来源
Computational Toxicology | 2019年 / 11卷
关键词
ADME prediction; In silico tools; PBK; PBPK; PBTK;
D O I
10.1016/j.comtox.2019.03.001
中图分类号
学科分类号
摘要
Since their inception in pharmaceutical applications, physiologically-based kinetic (PBK) models are increasingly being used across a range of sectors, such as safety assessment of cosmetics, food additives, consumer goods, pesticides and other chemicals. Such models can be used to construct organ-level concentration-time profiles of xenobiotics. These models are essential in determining the overall internal exposure to a chemical and hence its ability to elicit a biological response. There are a multitude of in silico resources available to assist in the construction and evaluation of PBK models. An overview of these resources is presented herein, encompassing all attributes required for PBK modelling. These include predictive tools and databases for physico-chemical properties and absorption, distribution, metabolism and elimination (ADME) related properties. Data sources for existing PBK models, bespoke PBK software and generic software that can assist in model development are also identified. On-going efforts to harmonise approaches to PBK model construction, evaluation and reporting that would help increase the uptake and acceptance of these models are also discussed. © 2019 Elsevier B.V.
引用
收藏
页码:33 / 49
页数:16
相关论文
共 50 条
  • [41] Estimation of background exposure to toluene using a physiologically-based kinetic model
    Pierce, CH
    Dills, RL
    Lewandowski, TA
    Morgan, MS
    Wessels, MA
    Shen, DD
    Kalman, DA
    JOURNAL OF OCCUPATIONAL HEALTH, 1997, 39 (02) : 130 - 137
  • [42] Simplification of Complex Physiologically-based Pharmacokinetic Models of Monoclonal Antibodies
    Elmeliegy, Mohamed
    Krzyzanski, Wojciech
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 : S29 - S30
  • [43] THE USE OF PHYSIOLOGICALLY-BASED MODELS TO SIMULATE ENANTIOSELECTIVE DIFFERENCES IN PHARMACOKINETICS
    PIOTROVSKIJ, VK
    SHVATCHKO, EV
    TRNOVEC, T
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1994, 16 (04): : 263 - 269
  • [44] Physiologically-based pharmacokinetic models for children: Starting to reach maturation?
    Verscheijden, Laurens F. M.
    Koenderink, Jan B.
    Johnson, Trevor N.
    de Wildt, Saskia N.
    Russel, Frans G. M.
    PHARMACOLOGY & THERAPEUTICS, 2020, 211
  • [45] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELS - MATHEMATICAL FUNDAMENTALS AND SIMULATION IMPLEMENTATIONS
    HOANG, KCT
    TOXICOLOGY LETTERS, 1995, 79 (1-3) : 99 - 106
  • [46] Lumping of physiologically-based pharmacokinetic models and a mechanistic derivation of classical compartmental models
    Sabine Pilari
    Wilhelm Huisinga
    Journal of Pharmacokinetics and Pharmacodynamics, 2010, 37 : 365 - 405
  • [47] Lumping of physiologically-based pharmacokinetic models and a mechanistic derivation of classical compartmental models
    Pilari, Sabine
    Huisinga, Wilhelm
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2010, 37 (04) : 365 - 405
  • [48] DEVELOPMENT OF A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL OF CANAGLIFLOZIN IN HUMANS.
    Courtois, K.
    Rower, J. E.
    Bradshaw-Pierce, E. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S35 - S35
  • [49] Pharmacokinetics and development of a physiologically-based pharmacokinetic model of docetaxel in mice
    Bradshaw-Pierce, Erica L.
    Merz, Andrea L.
    Zirrolli, Joseph A.
    Gustafson, Daniel L.
    CANCER RESEARCH, 2006, 66 (08)
  • [50] Development and application of a physiologically-based pharmacokinetic model for ractopamine in goats
    Ai, Jing
    Gao, Yunfeng
    Yang, Fan
    Zhao, Zhen
    Dong, Jin
    Wang, Jing
    Fu, Shiyi
    Ma, Ying
    Gu, Xu
    FRONTIERS IN VETERINARY SCIENCE, 2024, 11